Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $917,386 (100.0% shares, 0.0% debt)

Holdings (15)

AXSM AXSOME THERAPEUTICS INC 20.5%

Value ($000) $188,334 Shares 2,360,077 Est. Cost $49.79 Unrealized +68.6%

NUVL NUVALENT INC 15.8%

Value ($000) $144,520 Shares 1,924,626 Est. Cost $22.67 Unrealized +251.1%

APGE APOGEE THERAPEUTICS INC 14.8%

Value ($000) $136,133 Shares 2,048,647 Est. Cost $22.03 Unrealized +98.2%

DNTH DIANTHUS THERAPEUTICS INC 9.0%

Value ($000) $82,885 Shares 2,762,837 Est. Cost $15.37 Unrealized +41.4%

— KINIKSA PHARMACEUTICALS LTD 6.9%

Value ($000) $63,232 Shares 3,204,841 Est. Cost $16.91 Unrealized —

ELVN ENLIVEN THERAPEUTICS INC 6.1%

Value ($000) $56,337 Shares 3,202,798 Est. Cost $18.66 Unrealized -17.8%

— ASTRIA THERAPEUTICS INC 5.5%

Value ($000) $50,024 Shares 3,554,129 Est. Cost $9.99 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 3.5%

Value ($000) $32,320 Shares 1,845,813 Est. Cost $16.72 Unrealized +15.9%

— MERUS N V 3.5%

Value ($000) $32,298 Shares 717,254 Est. Cost $24.17 Unrealized —

COGT COGENT BIOSCIENCES INC 3.5%

Value ($000) $31,756 Shares 4,725,641 Est. Cost $8.83 Unrealized -30.0%

PTGX PROTAGONIST THERAPEUTICS INC 2.9%

Value ($000) $26,960 Shares 931,890 Est. Cost $27.21 Unrealized 0.0%

TYRA TYRA BIOSCIENCES INC 2.5%

Value ($000) $22,851 Shares 1,393,329 Est. Cost $14.88 Unrealized +10.2%

GERN GERON CORP 2.4%

Value ($000) $22,000 Shares 6,666,667 Est. Cost $2.23 Unrealized 0.0%

SYRE SPYRE THERAPEUTICS INC 1.6%

Value ($000) $14,354 Shares 378,421 Est. Cost $13.22 Unrealized +119.2%

TERN TERNS PHARMACEUTICALS INC 1.5%

Value ($000) $13,382 Shares 2,040,000 Est. Cost $3.72 Unrealized +75.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
AXSM	AXSOME THERAPEUTICS INC	2,360,077	$188,334	20.5%	$49.79	+68.6%	COM	05464T104
NUVL	NUVALENT INC	1,924,626	$144,520	15.8%	$22.67	+251.1%	COM	670703107
APGE	APOGEE THERAPEUTICS INC	2,048,647	$136,133	14.8%	$22.03	+98.2%	COM	03770N101
DNTH	DIANTHUS THERAPEUTICS INC	2,762,837	$82,885	9.0%	$15.37	+41.4%	COM	252828108
—	KINIKSA PHARMACEUTICALS LTD	3,204,841	$63,232	6.9%	$16.91	—	COM CL A	G5269C101
ELVN	ENLIVEN THERAPEUTICS INC	3,202,798	$56,337	6.1%	$18.66	-17.8%	COM	29337E102
—	ASTRIA THERAPEUTICS INC	3,554,129	$50,024	5.5%	$9.99	—	COM	04635X102
VRDN	VIRIDIAN THERAPEUTICS INC	1,845,813	$32,320	3.5%	$16.72	+15.9%	COM	92790C104
—	MERUS N V	717,254	$32,298	3.5%	$24.17	—	COM	N5749R100
COGT	COGENT BIOSCIENCES INC	4,725,641	$31,756	3.5%	$8.83	-30.0%	COM	19240Q201
PTGX	PROTAGONIST THERAPEUTICS INC	931,890	$26,960	2.9%	$27.21	0.0%	COM	74366E102
TYRA	TYRA BIOSCIENCES INC	1,393,329	$22,851	2.5%	$14.88	+10.2%	COM	90240B106
GERN	GERON CORP	6,666,667	$22,000	2.4%	$2.23	0.0%	COM	374163103
SYRE	SPYRE THERAPEUTICS INC	378,421	$14,354	1.6%	$13.22	+119.2%	COM NEW	00773J202
TERN	TERNS PHARMACEUTICALS INC	2,040,000	$13,382	1.5%	$3.72	+75.7%	COM	880881107